Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1

International Journal of Antimicrobial Agents

Volumn 41, Issue 2, 2013, Pages 156-161

  Jun, Soo Youn ^a   Jung, Gi Mo ^a   Yoon, Seong Jun ^a   Oh, Myoung Don ^b   Choi, Yun Jaie ^c   Lee, Woo Jong ^d   Kong, Joon Chan ^d   Seol, Jae Goo ^a   Kang, Sang Hyeon ^a  

^a INtRON Biotechnology Inc   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

^d Korea Institute of Industrial Technology   (South Korea)

Author keywords

Anti Staphylococcus aureus agent; Bactericidal; Phage endolysin; SAL 1

Indexed keywords

ANTIINFECTIVE AGENT; RECOMBINANT ENZYME; SAL 1; SAL200; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL VIABILITY; BACTERIUM COLONY; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; ERYTHEMA; FEMALE; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; ION EXCHANGE CHROMATOGRAPHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PTOSIS; SPLEEN; SURVIVAL RATE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; ENDOPEPTIDASES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRAL PROTEINS;

EID: 84872364303     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.10.011     Document Type: Article

References (21)

1. S. O'Flaherty, A. Coffey, W. Meaney, G.F. Fitzgerald, and R.P. Ross The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus J Bacteriol 187 2005 7161 7164 (Pubitemid 41428894)
2. S.Y. Jun, G.M. Jung, J.S. Son, S.J. Yoon, Y.J. Choi, and S.H. Kang Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK Antimicrob Agents Chemother 55 2011 1764 1767
3. S.C. Becker, J. Foster-Frey, and D.M. Donovan The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA FEMS Microbiol Lett 287 2008 185 191
4. L.Y. Filatova, S.C. Becker, D.M. Donovan, A.K. Gladilin, and N.L. Klyachko LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization Biochimie 92 2010 507 513
5. M. Horgan, G. O'Flynn, J. Garry, J. Cooney, A. Coffey, and G.F. Fitzgerald Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci Appl Environ Microbiol 75 2009 872 874
6. I. Young, I. Wang, and W.D. Roof Phages will out: strategies of host cell lysis Trends Microbiol 8 2000 120 128 (Pubitemid 30155487)
7. M.J. Loessner Bacteriophage endolysins - current state of research and applications Curr Opin Microbiol 8 2005 480 487 (Pubitemid 41021911)
8. M. Fenton, P. Ross, O. McAuliffe, J. O'Mahony, and A. Coffey Recombinant bacteriophage lysins as antibacterials Bioeng Bugs 1 2010 9 16
9. F.D. Lowy Antimicrobial resistance: the example of Staphylococcus aureus J Clin Invest 111 2003 1265 1273 (Pubitemid 36554694)
10. C.M. Kusuma, and J.F. Kokai-Kun Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus Antimicrob Agents Chemother 49 2005 3256 3263 (Pubitemid 41060569)
11. J.S. Son, S.J. Lee, S.Y. Jun, S.J. Yoon, S.H. Kang, and H.R. Paik Antibacterial and biofilm removal activity of a Podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme Appl Microbiol Biotechnol 86 2010 1439 1449
12. E.M. Butt, C.W. Bonynge, and R.L. Joyce The demonstration of capsules about hemolytic streptococci with India ink or A20 blue J Infect Dis 58 1936 5 9
13. J.A. Wu, C. Kusuma, J.J. Mond, and J.F. Kokai-Kun Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces Antimicrob Agent Chemother 47 2003 3407 3414 (Pubitemid 37345697)
14. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard. 9th ed. Document M7-A9. Wayne, PA: CLSI; 2012.
15. Clinical and Laboratory Standards Institute. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. Document M26-A. Wayne, PA: CLSI; 1999.
16. k eliminates Staphylococcus aureus in the nares of mice Bioeng Bugs 1 2010 404 407
17. M.W. LeChevallier, C.D. Cawthon, and R.G. Lee Factors promoting survival of bacteria in chlorinated water supplies Appl Environ Microbiol 54 1988 649 654 (Pubitemid 18069642)
18. R.W. Finberg, R.C. Moellering, F.P. Tally, W.A. Craig, G.A. Pankey, and E.P. Dellinger The importance of bactericidal drugs: future directions in infectious disease Clin Infect Dis 39 2004 1314 1320 (Pubitemid 39458517)
19. A. Daniel, C. Euler, M. Collin, P. Chahales, K.J. Gorelick, and V.A. Fischetti Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 54 2010 1603 1612
20. J. Gu, W. Xu, L. Lei, J. Huang, X. Feng, and C. Sun LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection J Clin Microbiol 49 2011 111 117
21. M. Rashel, J. Uchiyama, T. Ujihara, Y. Uehara, S. Kuramoto, and S. Sugihara Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φ MR11 J Infect Dis 196 2007 1237 1247 (Pubitemid 47580279)